or more than a decade, ‘8F-fluorodeoxyglucosehas been the most frequently used marker for positron emis sion tomography(PET) imagingof malignanttumors, as it is recognized that the rate of glycolysis is veiy often in creased in malignant cells (1—3).More recently, the use of FDG was proposed to monitor the efficacy of antitumoral treatment (4-8). Two nonPET markers widely used in cardiology to assess myocardial perfusion
melanin synthesis (1 1,12) and receptor binding (13) are also applicable for tumor diagnosis. The us...
Molecular imaging employing (18)[F]FDG-PET/CT enables in-vivo visualization, characterisation and me...
Positron emission tomography (PET) is a diagnostic imaging method to examine metabolic functions and...
Positron emission tomography (PET) is a diagnostic imaging technique that has progressed rapidly fro...
(F-i 8-FDG) has been widely used for the measurement of regional glucose metabolism in brain and hea...
ith the recent development of high spatial and temporal resolution positron emission tomography (PET...
following intravenous administration of the tracer. Positron-emitters contain an excess of protons i...
Positron emission computed tomography (PET) is a functional diagnostic imaging technique, which can ...
Positron emission tomography (PET) and positron emission tomography/computed tomography imaging with...
FDG, the most common radiopharmaceutical for PET imaging in oncology, is not tumor-specific. Signifi...
Patients suffering from malignant neoplasms will often undergo serial positron emission tomography- ...
POSITRON EMISSION TOMOGRAPHY (PET) using 18F-fluoro-2-deoxy-D-glucose (FDG) is widely used to evalua...
Accurate and early evaluation of tumor response to chemotherapy is a growing clinical need for optim...
Upregulated glucose metabolism in tumors and metastases can be visualized by PET using 18F‑fluoro‑2‑...
Positron Emission Tomography (PET) is a radiotracer imaging technique, in which tracer compounds lab...
melanin synthesis (1 1,12) and receptor binding (13) are also applicable for tumor diagnosis. The us...
Molecular imaging employing (18)[F]FDG-PET/CT enables in-vivo visualization, characterisation and me...
Positron emission tomography (PET) is a diagnostic imaging method to examine metabolic functions and...
Positron emission tomography (PET) is a diagnostic imaging technique that has progressed rapidly fro...
(F-i 8-FDG) has been widely used for the measurement of regional glucose metabolism in brain and hea...
ith the recent development of high spatial and temporal resolution positron emission tomography (PET...
following intravenous administration of the tracer. Positron-emitters contain an excess of protons i...
Positron emission computed tomography (PET) is a functional diagnostic imaging technique, which can ...
Positron emission tomography (PET) and positron emission tomography/computed tomography imaging with...
FDG, the most common radiopharmaceutical for PET imaging in oncology, is not tumor-specific. Signifi...
Patients suffering from malignant neoplasms will often undergo serial positron emission tomography- ...
POSITRON EMISSION TOMOGRAPHY (PET) using 18F-fluoro-2-deoxy-D-glucose (FDG) is widely used to evalua...
Accurate and early evaluation of tumor response to chemotherapy is a growing clinical need for optim...
Upregulated glucose metabolism in tumors and metastases can be visualized by PET using 18F‑fluoro‑2‑...
Positron Emission Tomography (PET) is a radiotracer imaging technique, in which tracer compounds lab...
melanin synthesis (1 1,12) and receptor binding (13) are also applicable for tumor diagnosis. The us...
Molecular imaging employing (18)[F]FDG-PET/CT enables in-vivo visualization, characterisation and me...
Positron emission tomography (PET) is a diagnostic imaging method to examine metabolic functions and...